Kristiina Iljin

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Kristiina Iljin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
Prostatic Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Genes Medicine & Life Sciences
RNA Interference Medicine & Life Sciences
Cell Movement Medicine & Life Sciences
Androgens Medicine & Life Sciences
Epithelial-Mesenchymal Transition Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2006 2019

Layered material platform for surface plasmon resonance biosensing

Wu, F., Thomas, P. A., Kravets, V. G., Arola, H. O., Soikkeli, M., Iljin, K., Kim, G., Kim, M., Shin, H. S., Andreeva, D. V., Neumann, C., Küllmer, M., Turchanin, A., De Fazio, D., Balci, O., Babenko, V., Luo, B., Goykhman, I., Hofmann, S., Ferrari, A. C. & 2 others, Novoselov, K. S. & Grigorenko, A. N., 30 Dec 2019, In : Scientific Reports. 9, 1, 20286.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
Surface Plasmon Resonance
Food Safety
2 Citations (Scopus)

Identifying the druggable interactome of EWS-FLI1 reveals MCL-1 dependent differential sensitivities of Ewing sarcoma cells to apoptosis inducers

Tsafou, K., Katschnig, A. M., Radic-Sarikas, B., Mutz, C. N., Iljin, K., Schwentner, R., Kauer, M. O., Mühlbacher, K., Aryee, D. N. T., Westergaard, D., Haapa-Paananen, S., Fey, V., Superti-Furga, G., Toretsky, J., Brunak, S. & Kovar, H., 24 Jul 2018, In : Oncotarget. 9, 57, p. 31018-31031 14 p.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
Ewing's Sarcoma
Oncogene Fusion
Histone Code
RNA Sequence Analysis
4 Citations (Scopus)

High-throughput RNAi screen in Ewing sarcoma cells identifies leucine rich repeats and WD repeat domain containing 1 (LRWD1) as a regulator of EWS-FLI1 driven cell viability

He, T., Surdez, D., Rantala, J. K. ., Haapa-Paananen, S., Ban, J., Kauer, M., Tomazou, E., Fey, V., Alonso, J., Kovar, H., Delattre, O. & Iljin, K., 5 Jan 2017, In : Gene. 596, p. 137-146 10 p.

Research output: Contribution to journalArticleScientificpeer-review

Ewing's Sarcoma
RNA Interference
Cell Survival
9 Citations (Scopus)

Retinoic acid and TGF-ß signalling cooperate to overcome MYCN-induced retinoid resistance

Duffy, D. J., Krstic, A., Halasz, M., Schwarzl, T., Konietzny, A., Iljin, K., Higgins, D. G. & Kolch, W., 10 Feb 2017, In : Genome Medicine. 9, 1, p. 15 15.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
Transforming Growth Factor beta

High-throughput cell-based compound screen identifies pinosylvin methyl ether and tanshinone IIA as inhibitors of castration-resistant prostate cancer

Ketola, K., Viitala, M., Kohonen, P., Fey, V., Culig, Z., Kallioniemi, O. & Iljin, K., 2016, In : Journal of Molecular Biochemistry. 5, p. 12-22

Research output: Contribution to journalArticleScientificpeer-review

Methyl Ethers
Prostatic Neoplasms
Pharmaceutical Preparations